Literature DB >> 23768693

Preventive health care and owner-reported disease prevalence of horses and ponies in Great Britain.

J L Ireland1, C E Wylie, S N Collins, K L P Verheyen, J R Newton.   

Abstract

This study aimed to describe the provision of preventive health care and owner-reported disease prevalence in horses and ponies within Great Britain (GB), and to assess geographical variations in health care provision. A cross-sectional survey was conducted, using a postal questionnaire administered to a random sample of veterinary-registered owners of horses and ponies in GB (n=797). The majority of animals received regular preventive health care: 95.6% had regular hoof care; 71.3% were vaccinated for both influenza and tetanus and median time since last anthelmintic administration was 8.7 weeks. Thirty-one percent of owners indicated their animal was overweight/obese. A new health problem within the previous 7 days was reported for 7.4% of animals, 59.3% of which were veterinary-diagnosed. Thirty-two percent of animals were reported to have a long-term/recurrent condition, of which osteoarthritis (13.9%) was the most prevalent. Obesity, musculoskeletal disorders, and dermatological conditions were the most prevalent conditions affecting veterinary-registered horses/ponies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disease prevalence; Epidemiology; Equine; Preventive health care; Survey

Mesh:

Year:  2013        PMID: 23768693     DOI: 10.1016/j.rvsc.2013.05.007

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  14 in total

1.  Equine pituitary pars intermedia dysfunction: An international survey of veterinarians' approach to diagnosis, management, and estimated prevalence.

Authors:  James L Carmalt; Cheryl L Waldner; Andrew L Allen
Journal:  Can J Vet Res       Date:  2017-10       Impact factor: 1.310

2.  Global positioning system derived performance measures are responsive indicators of physical activity, disease and the success of clinical treatments in domestic dogs.

Authors:  Elizabeth A Bruno; James W Guthrie; Stephen A Ellwood; Richard J Mellanby; Dylan N Clements
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

3.  Prevalence and risk factors for overweight horses at premises in Sweden assessed using official animal welfare control data.

Authors:  Peta L Hitchens; Jan Hultgren; Jenny Frössling; Ulf Emanuelson; Linda J Keeling
Journal:  Acta Vet Scand       Date:  2016-10-20       Impact factor: 1.695

4.  Mouldable, thermoplastic, glue-on frog-supportive shoes change hoof kinetics in normal and obese Shetland ponies.

Authors:  J Sleutjens; F M Serra Bragança; M W van Empelen; R E Ten Have; J de Zwaan; E Roelfsema; M Oosterlinck; W Back
Journal:  Equine Vet J       Date:  2018-02-12       Impact factor: 2.888

Review 5.  Undenatured Type II Collagen (UC-II) in Joint Health and Disease: A Review on the Current Knowledge of Companion Animals.

Authors:  Hasan Gencoglu; Cemal Orhan; Emre Sahin; Kazim Sahin
Journal:  Animals (Basel)       Date:  2020-04-17       Impact factor: 2.752

6.  Potential and Challenges of Community-Based Surveillance in Animal Health: A Pilot Study Among Equine Owners in Switzerland.

Authors:  Ranya Özçelik; Franziska Remy-Wohlfender; Susanne Küker; Vivianne Visschers; Daniela Hadorn; Salome Dürr
Journal:  Front Vet Sci       Date:  2021-06-04

Review 7.  A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Authors:  Romain Paillot
Journal:  Vaccines (Basel)       Date:  2014-11-14

8.  Current Welfare Problems Facing Horses in Great Britain as Identified by Equine Stakeholders.

Authors:  Susan V Horseman; Henry Buller; Siobhan Mullan; Helen R Whay
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

9.  Maternal obesity increases insulin resistance, low-grade inflammation and osteochondrosis lesions in foals and yearlings until 18 months of age.

Authors:  M Robles; E Nouveau; C Gautier; L Mendoza; C Dubois; M Dahirel; B Lagofun; M-C Aubrière; J-P Lejeune; I Caudron; I Guenon; C Viguié; L Wimel; H Bouraima-Lelong; D Serteyn; A Couturier-Tarrade; P Chavatte-Palmer
Journal:  PLoS One       Date:  2018-01-26       Impact factor: 3.240

10.  Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment.

Authors:  Simone Gabner; Reinhard Ertl; Karsten Velde; Matthias Renner; Florien Jenner; Monika Egerbacher; Juraj Hlavaty
Journal:  J Gene Med       Date:  2018-04-22       Impact factor: 4.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.